CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration (AMD) suggested a potential annual savings of $3,200 per patient, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results